BE820254A - Nouvelle forme d'administration de la n-4-(2-(5-chloro-2-methoxybenzamido)- ethyl)-phenyl-sulfonyl-n'-cyclohexyl-uree - Google Patents

Nouvelle forme d'administration de la n-4-(2-(5-chloro-2-methoxybenzamido)- ethyl)-phenyl-sulfonyl-n'-cyclohexyl-uree

Info

Publication number
BE820254A
BE820254A BE148814A BE148814A BE820254A BE 820254 A BE820254 A BE 820254A BE 148814 A BE148814 A BE 148814A BE 148814 A BE148814 A BE 148814A BE 820254 A BE820254 A BE 820254A
Authority
BE
Belgium
Prior art keywords
uree
methoxybenzamido
sulfonyl
cyclohexyl
chloro
Prior art date
Application number
BE148814A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE820254A publication Critical patent/BE820254A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE148814A 1973-09-26 1974-09-24 Nouvelle forme d'administration de la n-4-(2-(5-chloro-2-methoxybenzamido)- ethyl)-phenyl-sulfonyl-n'-cyclohexyl-uree BE820254A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2348334A DE2348334C2 (de) 1973-09-26 1973-09-26 Neue Zubereitungsform des N-4-[2-(5-Chlor-2-methoxybenzamido)äthyl]- phenyl-sulfonyl-N'-cyclohexylharnstoffs

Publications (1)

Publication Number Publication Date
BE820254A true BE820254A (fr) 1975-03-24

Family

ID=5893666

Family Applications (1)

Application Number Title Priority Date Filing Date
BE148814A BE820254A (fr) 1973-09-26 1974-09-24 Nouvelle forme d'administration de la n-4-(2-(5-chloro-2-methoxybenzamido)- ethyl)-phenyl-sulfonyl-n'-cyclohexyl-uree

Country Status (12)

Country Link
US (1) US3979520A (xx)
JP (1) JPS5632967B2 (xx)
AT (1) AT330954B (xx)
BE (1) BE820254A (xx)
CA (1) CA1029661A (xx)
DE (1) DE2348334C2 (xx)
FI (1) FI58068C (xx)
FR (1) FR2244455B1 (xx)
GB (1) GB1420907A (xx)
NL (1) NL174222C (xx)
SE (1) SE402210B (xx)
ZA (1) ZA745967B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3033919A1 (de) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
DE3326167A1 (de) * 1983-07-20 1985-02-21 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Feste arzneiformen, die als wirkstoff n-4-(2-(5-chlor-2-methoxybenzamido)-ethyl)-phenylsulfonyl-n'-cyclohexylharnstoff enthalten und verfahren zu ihrer herstellung
US4826689A (en) * 1984-05-21 1989-05-02 University Of Rochester Method for making uniformly sized particles from water-insoluble organic compounds
CA1282405C (en) * 1984-05-21 1991-04-02 Michael R. Violante Method for making uniformly sized particles from water-insoluble organic compounds
US4916163A (en) * 1985-06-04 1990-04-10 The Upjohn Company Spray-dried lactose formulation of micronized glyburide
DE3833439A1 (de) * 1988-10-01 1991-09-12 Hoechst Ag Verfahren zur mikronisierung von glibenclamid
SE464743B (sv) * 1989-06-21 1991-06-10 Ytkemiska Inst Foerfarande foer framstaellning av laekemedelspartiklar
US5258185A (en) * 1989-08-23 1993-11-02 Bauer Kurt H Highly active, rapidly absorbable formulations of glibenclamide, processes for the production thereof and their use
NZ302926A (en) * 1995-02-28 1998-10-28 Hoechst Marion Roussel Inc Composition for use as antihistamines comprising piperidinoalkanol derivatives and inert ingredients
PT998272E (pt) * 1997-08-26 2003-09-30 Aventis Pharma Inc Composicao farmaceutica para combinacao do descongestionante piperidinoalcanol
ATE250418T1 (de) 1998-07-15 2003-10-15 Merck Sante Sas Tabletten enthaltend eine kombination von glibenclamid und metformin
US6586438B2 (en) 1999-11-03 2003-07-01 Bristol-Myers Squibb Co. Antidiabetic formulation and method
US20010036479A1 (en) * 2000-01-14 2001-11-01 Gillian Cave Glyburide composition
WO2006109175A2 (en) * 2005-04-11 2006-10-19 Aurobindo Pharma Limited Solid dosage form of an antidiabetic drug
CN104098489A (zh) * 2014-07-10 2014-10-15 沈阳药科大学 一种微粉化格列本脲及其组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB694280A (en) * 1950-09-19 1953-07-15 Merck & Co Inc A stable, non-caking suspension of cortisone acetate in an isotonic aqueous vehicle and the process of preparing said composition
US3008873A (en) * 1957-02-07 1961-11-14 Merck & Co Inc Controlled particle size of 4, 4-dinitrocarbanilide
GB1030395A (en) * 1962-12-26 1966-05-25 Upjohn Co Hypoglycemic sulphonyl urea medicaments
US3401221A (en) * 1964-08-25 1968-09-10 Norwich Pharma Co Treatment of urinary tract infection
US3454635A (en) * 1965-07-27 1969-07-08 Hoechst Ag Benzenesulfonyl-ureas and process for their manufacture
DE2017495A1 (en) * 1970-04-11 1971-11-04 Merck Patent Gmbh, 6100 Darmstadt Sulphonamides embedded in galactomannans
JPS4932056B1 (xx) * 1970-12-22 1974-08-27

Also Published As

Publication number Publication date
SE7412044L (xx) 1975-03-27
FI275574A (xx) 1975-03-27
FI58068C (fi) 1980-12-10
JPS5058216A (xx) 1975-05-21
FI58068B (fi) 1980-08-29
FR2244455A1 (xx) 1975-04-18
ZA745967B (en) 1975-11-26
US3979520A (en) 1976-09-07
FR2244455B1 (xx) 1978-07-21
ATA762374A (de) 1975-10-15
GB1420907A (en) 1976-01-14
AT330954B (de) 1976-07-26
NL7412393A (nl) 1975-04-01
DE2348334A1 (de) 1975-03-27
JPS5632967B2 (xx) 1981-07-31
SE402210B (sv) 1978-06-26
CA1029661A (en) 1978-04-18
NL174222B (nl) 1983-12-16
NL174222C (nl) 1984-05-16
AU7365374A (en) 1976-04-01
DE2348334C2 (de) 1982-11-11

Similar Documents

Publication Publication Date Title
BE820254A (fr) Nouvelle forme d'administration de la n-4-(2-(5-chloro-2-methoxybenzamido)- ethyl)-phenyl-sulfonyl-n'-cyclohexyl-uree
IT1023490B (it) Procedimento per la produzione di alchilalcossisilan contenenti ponti polisolfurio
BE814790A (fr) Nouveaux derives d'arylthioalcanols
BE821406A (fr) Derives de 1
BE818954A (fr) Nouvelle composition de blanchiment-fixage
BE822990A (fr) Procede pour la preparation d'hexamethyltetraline
BE823424A (fr) Derives d'oxazole
BE811680A (fr) Perfectionnements relatifs a la preparation d'un produit enzymatique
BE820789A (fr) Nouveaux derives de l'isoquinoleine
BE814140A (fr) Distributeur d'essuie-mains
RO66809A (ro) Diblu de spraituire
DK137239C (da) Fremgangsmaade til fremstilling af terapeutisk aktive 2-(3'-hydroxyphenyl)-1-oxa-4-azaspiroalkan-derivater
BE815624A (fr) Preparation de compositions d'elastomeres fluores
BE816049A (fr) Derives d'acides benzodioxole-1
BE817917A (fr) Amides derives de l'isoquinoleine
AR207242A1 (es) Procedimiento de preparacion de nuevos derivados de pirazolonas-(5)-1-substituidas
IT1020644B (it) Procedimento per la preparazione di ammidi di acidi
BE813547A (fr) Derives alkyles d'acides prostanoiques et leur preparation
TR18351A (tr) Poli - n-alkiliminialan'larin hazirlanmasi
RO70080A (ro) Procedeu de preparare a n-arilsulfonil-n'-(aza-3-bicicloalchil)-ureelor
BE805912A (fr) Structure d'electrode pour installation d'electroclimatisation
IT1012820B (it) Processo per la preparazione di 1 cloroantrachinone
BE811007A (fr) Marquage d'articles de forme
AR203359A1 (es) Procedimiento para la produccion de nuevas n'-(aminoacilaminofenil)-acetamidinas
IT1014978B (it) Processo per la preparazione di 5 ossoesannitrile

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BOEHRINGER MANNHEIM G.M.B.H.

Effective date: 19910930